Self-regulation of autologous cell therapies

Bernard E Tuch and Dominic Wall
Med J Aust 2014; 201 (9): . || doi: 10.5694/mja14.01069
Published online: 3 November 2014

In reply: We agree with Vesey on the need for clinical governance, but urge him to remain involved with the development of a national code of conduct in this area. His company's experience would be invaluable. Our observations regarding self-regulation were qualified because, unlike the fertility treatments, many of the therapeutic claims of autologous cell therapies are unproven. Consequently, there should be a goal of developing an evidence framework.

  • Bernard E Tuch1,2
  • Dominic Wall3,4

  • 1 NSW Stem Cell Network, Sydney, NSW.
  • 2 Centre for Genetic Diseases, Monash Institute of Medical Research, Monash University, Melbourne, VIC.
  • 3 Australia and New Zealand Region, International Society for Cellular Therapy, Melbourne, VIC.
  • 4 Department of Pathology, University of Melbourne, Melbourne, VIC.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.